Isolation and Identification of Cucurbitane-type Triterpenoids with Partial Agonist/antagonist Potential for Estrogen Receptors from Momordica Charantia
Overview
Nutritional Sciences
Affiliations
This study aims at investigating the estrogenic activity and active cucurbitane-type triterpenoid compounds of bitter gourd (Momordica charantia, MC) using a transactivation assay for estrogen receptors (ER) α and β. The lyophilized fruits of MC were exhaustively extracted with ethyl acetate (EA) and 95% ethanol (EtOH), sequentially. The nonsaponifiable fraction (NS) of the EA extract as well as the acid hydrolyzed EtOH extract (AH) was fractionated and isolated by repeated column chromatography and further purified by preparative HPLC or RP-HPLC. One known compound, 5β,19-epoxycucurbita-6,24-diene-3β,23ξ-diol (6), was isolated from the NS, and five new compounds (1-5) were isolated from AH and identified as cucurbita-6,22(E),24-trien-3β-ol-19,5β-olide (1), 5β,19-epoxycucurbita-6,22(E),24-triene-3β,19-diol (2), 3β-hydroxycucurbita-5(10),6,22(E),24-tetraen-19-al (3), 19-dimethoxycucurbita-5(10),6,22(E),24-tetraen-3β-ol (4), and 19-nor-cucurbita-5(10),6,8,22(E),24-pentaen-3β-ol (5). In the noncytotoxic concentration range, compounds 1, 2, 5 and 6 showed weak agonistic activity via ER α and β. Compounds 1, 2, 3 and 6 significantly antagonized the transactvation of 17β-estradiol (E(2)) via both ER α and β. In conclusion, this study demonstrates, for the first time as far as we know, the partial agonist/antagonist activity via ER of four new and one known cucurbitane-type triterpenoids from MC. Further studies are worthy to explore the selective estrogen receptor modulator (SERM) activity of MC.
L.-Diabetes-Related Bioactivities, Quality Control, and Safety Considerations.
Cicek S Front Pharmacol. 2022; 13:904643.
PMID: 35656300 PMC: 9152207. DOI: 10.3389/fphar.2022.904643.
Kung W, Lin M Int J Mol Sci. 2021; 22(7).
PMID: 33804820 PMC: 8037269. DOI: 10.3390/ijms22073289.
Natural Compounds in Sex Hormone-Dependent Cancers: The Role of Triterpenes as Therapeutic Agents.
Soica C, Voicu M, Ghiulai R, Dehelean C, Racoviceanu R, Trandafirescu C Front Endocrinol (Lausanne). 2021; 11:612396.
PMID: 33552000 PMC: 7859451. DOI: 10.3389/fendo.2020.612396.
Chen G, Chen W, Tseng K, Chao P Lipids Health Dis. 2017; 16(1):186.
PMID: 28962621 PMC: 5622538. DOI: 10.1186/s12944-017-0578-3.
Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
Raina K, Kumar D, Agarwal R Semin Cancer Biol. 2016; 40-41:116-129.
PMID: 27452666 PMC: 5067200. DOI: 10.1016/j.semcancer.2016.07.002.